Stay updated with breaking news from Meg Doherty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MONTREAL - Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a
Ninety countries will benefit from a voluntary licensing agreement announced on Thursday that will enable generic companies to produce a long-acting injectable antiretroviral, cabotegravir (CAB-LA), to protect people from HIV infection.
WHO Approves Use Of A New HIV Prevention Drug
MONTREAL - South Africa is home to the biggest community of people with HIV, but more of its citizens are now dying of diabetes than HIV and the country is
GENEVA: A deal has been reached to allow for distribution of a low-cost generic version of a long-term preventative treatment against HIV in low-income countries where most of the world's infections...